Lake Geauga Recovery Centers Inc Mens Residential Trt Lake House
-
Services:
- No formal relationship with prescribing entity
- Sliding fee scale (fee is based on income and other factors)
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Prescribes buprenorphine
- Maintenance service with medically supervised withdrawal after stabilization
- Family counseling
- Health education services other than HIV/AIDS or hepatitis
- Substance use disorder education
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Group counseling
- Individual counseling
- Assistance with obtaining social services
- Housing services
- Mentoring/peer support
- Self-help groups
- Employment counseling or training
- Treatment for gambling disorder
- Adults
- Young Adults
- Suicide prevention services
- Child care for clients’ children
- Early intervention for HIV
- Mental health services
- Transportation assistance
- Social skills development
- Case management service
- Residential beds for clients’ children
- Domestic violence services, including family or partner
- Vaping permitted in designated area
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- HIV testing
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State mental health department
- State Substance use treatment agency
- Anger management
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
- Contingency management/motivational incentives
- Substance use disorder counseling
- Motivational interviewing
- 12-step facilitation
- Trauma-related counseling
- Relapse prevention
- Brief intervention
- Sign language services for the deaf and hard of hearing
- Smoking permitted in designated area
- Transitional housing, halfway house, or sober home
- Substance use treatment
- Aftercare/continuing care
- Discharge Planning
- Outcome follow-up after discharge
- Naloxone and overdose education
- No formal relationship with prescribing entity
- Screening for substance use
- Screening for tobacco use
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Comprehensive mental health assessment
- Screening for mental disorders
- Male
- Medicare
- Medicaid
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- Cash or self-payment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Private non-profit organization
- Outpatient methadone/buprenorphine or naltrexone treatment
- Residential/24-hour residential
- Regular outpatient treatment
- Intensive outpatient treatment
- Outpatient
- Long-term residential
- Clients with co-occurring mental and substance use disorders
- Adult men
- Criminal justice (other than DUI/DWI)/Forensic clients
- Nicotine replacement
- Disulfiram
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Naltrexone (oral)
- Buprenorphine with naloxone
- Buprenorphine (extended-release, injectable)
- Acamprosate (CampralĀ®)
- Naltrexone (extended-release, injectable)
External Opioid Medications Source
Payment Assistance Available
Type of Opioid Treatment
Education and Counseling Services
Recovery Support Services
Other Services
Age Groups Accepted
Ancillary Services
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Testing
License/Certification/Accreditation
Treatment Approaches
Language Services
Facility Smoking Policy
Type of Care
Transitional Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Assessment/Pre-treatment
Gender Accepted
Payment/Insurance/Funding Accepted
Opioid Medications used in Treatment
Facility Operation (e.g., Private, Public)
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Pharmacotherapies